Impact of an intervention on the prescription of aliskiren after new evidence on safety reported. [electronic resource]
Producer: 20171004Description: 91-96 p. digitalISSN:- 1099-1557
- Amides -- administration & dosage
- Angiotensin Receptor Antagonists -- administration & dosage
- Angiotensin-Converting Enzyme Inhibitors -- administration & dosage
- Antihypertensive Agents -- administration & dosage
- Diabetes Mellitus -- drug therapy
- Electronic Health Records
- Fumarates -- administration & dosage
- Humans
- Interrupted Time Series Analysis
- Practice Patterns, Physicians' -- standards
- Primary Health Care
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.